Ot Broadcast News
The Disappointment of the NSABP C-08 Trial
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:09:05
- More information
Informações:
Synopsis
Norman Wolmark on the study's frustrating but unequivocal results showing that bevacizumab did not extend disease-free survival in adjuvant therapy for early colon cancer at 3 years, even though there had been a benefit at 1 year. Also weighing in: Nicholas Petrelli
